Instability of Anticoagulation Intensity Contributes to Occurrence of Ischemic Stroke in Patients With Non-Rheumatic Atrial Fibrillation.
- 1 January 2001
- journal article
- Published by Japanese Circulation Society in Japanese Circulation Journal
- Vol. 65 (5) , 404-408
- https://doi.org/10.1253/jcj.65.404
Abstract
The efficacy of anticoagulation in reducing the risk of cardiogenic embolism has been demonstrated in patients with atrial fibrillation (AF), but there are few prospective studies assessing the influence of anticoagulation stability on ischemic stroke in such patients. Accordingly, the present study investigated prospectively whether an instability of the anticoagulation intensity would affect the efficacy of the therapy in a total of 156 patients with non-rheumatic AF (NRAF) who received oral anticoagulation with warfarin. During a 2-year follow-up period, the annual event rate of ischemic stroke was 2.1%. In patients without a history of prior stroke, no ischemic stroke occurred at a higher international normalized ratio (INR ≥2.0). In contrast, patients who had had a prior stroke had no INR-dependent reduction of incidence. The coefficient of variation (CV) of measured INRs was significantly greater in patients with ischemic stroke than in those without. By multivariate analysis, only greater CV (≥0.3) of INRs was an independent risk for ischemic stroke, although New York Heart Association functional class ≥ II and treatment with diuretics were of borderline significance by univariate analysis. The present results suggest that stability of anticoagulation intensity is important to protect thromboembolic events in patients with NRAF. (Jpn Circ J 2001; 65: 404 - 408)Keywords
This publication has 23 references indexed in Scilit:
- Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation InvestigatorsArchives of internal medicine (1960), 1996
- Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?Archives of internal medicine (1960), 1994
- Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArchives of internal medicine (1960), 1994
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Increased intracardiovascular clotting in patients with chronic atrial fibrillationJournal of the American College of Cardiology, 1990
- Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.Journal of Clinical Pathology, 1990
- Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.Stroke, 1989
- The Natural History of Lone Atrial FibrillationNew England Journal of Medicine, 1987
- Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham StudyJAMA, 1985